Open Beta
TREN
MetriLume
TREN

US marketsOBIO

SEC-sourced researchBeta

OBIO

Orchestra BioMed Holdings, Inc.

Company comparison ↗

Data passport

CIK
0001814114
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 2,638,000.0000 USD; December 2025: 33,482,000.0000 USD33.5M USD0 USD0December 2024December 2025
OBIO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20242,638,000.0000Mar 12, 2026
December 202533,482,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202533,482,000.0000-52,701,000.0000-48,963,000.0000114,857,000.000051,479,000.0000Mar 12, 2026
December 20242,638,000.0000-61,024,000.0000-50,558,000.000076,173,000.000043,215,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$33.48MDecember 2025Mar 12, 202610-K
Previous period revenueRevenues$2.64MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$52.7MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$48.96MDecember 2025Mar 12, 202610-K
Total assetsAssets$114.86MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$51.48MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗